ADDRENEX PHARMACEUTICALS

addrenex-pharmaceuticals-logo

Addrenex Pharmaceuticals is based in Durham, NC on the edge of Research Triangle Park. Addrenex is a focused, specialty pharmaceutical company that develops drugs to regulate the adrenergic system. The company was founded in 2006 by a drug development expert and a practicing physician. Addrenex identified adrenergic regulation because expertise of the founders and the large number of medical conditions that are affected by a dysfunctional adrenergic system.

#SimilarOrganizations #People #Website #More

ADDRENEX PHARMACEUTICALS

Industry:
Biotechnology Health Care Medical

Founded:
2006-01-01

Address:
Durham, North Carolina, United States

Country:
United States

Website Url:
http://www.addrenex.com

Total Employee:
11+

Status:
Active

Contact:
919-941-0800

Technology used in webpage:
SPF SEDO DNS


Similar Organizations

not_available_image

Synaptic Pharmaceuticals

Synaptic Pharmaceuticals develops human receptor-targeted drug design technology.

Founder


moise-khayrallah_image

Moise Khayrallah

Official Site Inspections

http://www.addrenex.com

  • Host name: ip39.ip-188-165-72.eu
  • IP address: 188.165.72.39
  • Location: France
  • Latitude: 48.8582
  • Longitude: 2.3387
  • Timezone: Europe/Paris

Loading ...

More informations about "Addrenex Pharmaceuticals"

Addrenex Pharmaceuticals - Crunchbase Company Profile & Funding

Addrenex Pharmaceuticals is based in Durham, NC on the edge of Research Triangle Park. Addrenex is a focused, specialty pharmaceutical company that develops drugs to regulate the โ€ฆSee details»

Nurturing Mental Well-being in Fast-paced Societies

Chronic pain is a pervasive issue that affects millions of individuals, significantly impacting their quality of life. In the search for effective management strategies, CBD has emerged as a โ€ฆSee details»

Addrenex Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...

Explore Addrenex Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 1 literature, Drug:ADX-415.See details»

Addrenex Pharmaceuticals - Company Profile - Tracxn

Addrenex Pharmaceuticals is a specialty pharmaceutical company that develops drugs to regulate the adrenergic system. Its lead products are Clonicel(R) for the treatment of attention-deficit โ€ฆSee details»

Addrenex Pharmaceuticals - Overview, News & Competitors

Addrenex is a focused, specialty pharmaceutical company that develops drugs to regulate the adrenergic system. The company was founded in 2006 by a drug development expert and a โ€ฆSee details»

Addrenex Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

Addrenex Pharmaceuticals is a focused, specialty pharmaceutical company that develops and commercializes drugs to treat adrenergic dysregulation. Use the CB Insights Platform to โ€ฆSee details»

Addrenex Pharmaceuticals Inc - Company Profile and News

Addrenex Pharmaceuticals, Inc. is a pharmaceutical company. The Company develops drugs to normalize adrenergic function. Addrenex Pharmaceuticals also manufactures drugs to treat โ€ฆSee details»

Addrenex Pharmaceuticals - Crunchbase

Addrenex Pharmaceuticals develops drugs to regulate the adrenergic system.See details»

Addrenex Pharmaceuticals - Updates, News, Events, Signals

Addrenex Pharmaceuticals develops drugs to regulate the adrenergic system.See details»

Addrenex Pharmaceuticals Inc. - BioCentury Company Profiles - BCIQ

May 25, 2016 Addrenex Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»

Addrenex - Products, Competitors, Financials, Employees, โ€ฆ

Use the CB Insights Platform to explore Addrenex's full profile. Addrenex - Products, Competitors, Financials, Employees, Headquarters Locations Technology VendorsSee details»

Addrenex Pharmaceuticalsโ€™ New Hires Further Company Goal

Aug 20, 2008 To identify new drug candidates, Addrenex will delve into its vast library of 400 adrenergic compounds, housed at the University of Nebraska Medical Center. Addrenex โ€ฆSee details»

Addrenex Pharmaceuticals Licenses New Compound to Sciele โ€ฆ

DURHAM, N.C., July 1 /PRNewswire/ -- Two years after Addrenex Pharmaceuticals set it sights on building a new class of drugs to regulate "adrenergic excess," the small Durham company โ€ฆSee details»

Addrenex Management Team - CB Insights

Explore {Addrenex's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Addrenex CEO, Founder, Key โ€ฆSee details»

Meditation - addrenex.com

The art of mindful breathing, though seemingly simple, is a profound practice with enormous implications for your well-being. It opens the gateway to serenity and mindfulness, paving the โ€ฆSee details»

Addrenex Scores in ADHD Trial | North Carolina Biotechnology โ€ฆ

Apr 23, 2009 Addrenex plans to seek approval from the U.S. Food and Drug Administration later this year for Clonicel as both a monotherapy and as an add-on therapy to stimulant medication โ€ฆSee details»

Addrenex Pharmaceuticals Expands Product Pipeline by ... - BioSpace

May 13, 2009 Addrenex plans to begin phase 2 testing of ADX-N05 as a treatment for narcolepsy later this year. The company may also investigate ADX-N05 as adjunct therapy for โ€ฆSee details»

Addrenex Obtains Early-Stage Narcolepsy Drug from SK Holdings

May 13, 2009 Addrenex Pharmaceuticals will obtain rights to ADX-N05 from SK Holdings, a South Korean company, to expand its pipeline of adrenergic-regulating drugs. ADX-N05 is โ€ฆSee details»

Addrenex Pharmaceuticals Reaches Milestone with Filing of

Feb 20, 2008 Addrenex's goal is to develop a diverse pipeline of products aimed at regulating the adrenergic system, a vast and varied regulator of multiple bodily processes. The alpha-2 โ€ฆSee details»

Health - addrenex.com

In an era where convenience and technology have transformed our routines, the humble art of walking is often overlooked. However, this elemental act of mobility is not just a means to โ€ฆSee details»

linkstock.net © 2022. All rights reserved